Anti–PD-1 Therapy in Melanoma
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference71 articles.
1. Current developments in cancer vaccines and cellular immunotherapy;Ribas;J Clin Oncol,2003
2. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N Engl J Med,2010
3. Cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma: a new cause of uveitis;Robinson;J Immunother,2004
4. PD-1 and PD-1 ligands: from discovery to clinical application;Okazaki;Int Immunol,2007
5. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta;Sheppard;FEBS Lett,2004
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0;Molecular Cancer Therapeutics;2024-04-24
2. A Regularized Cox Hierarchical Model for Incorporating Annotation Information in Predictive Omic Studies;2024-03-11
3. Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target;Proceedings of the National Academy of Sciences;2023-03-09
4. Sequential administration of pemetrexed and cisplatin reprograms tumor immune microenvironment and potentiates PD-1/PD-L1 treatment in a lung cancer model;Journal of Investigative Medicine;2021-12-06
5. A novel multifunctional vaccine platform with dendritic cell-targeting and pH-responsive for cancer immunotherapy: Antigen-directed biomimetic fabrication of a cabbage-like mannatide-zinc-antigen hybrid microparticles;Chemical Engineering Journal;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3